Healius Limited Share Price

Equities

HLS

AU0000033359

Healthcare Facilities & Services

Market Closed - Australian S.E. 07:10:37 15/05/2024 BST 5-day change 1st Jan Change
1.26 AUD -5.97% Intraday chart for Healius Limited -1.56% -22.94%

Financials

Sales 2024 * 1.72B 1.14B 90.48B Sales 2025 * 1.8B 1.2B 94.97B Capitalization 973M 646M 51.32B
Net income 2024 * -632M -420M -33.34B Net income 2025 * 26M 17.27M 1.37B EV / Sales 2024 * 1.44 x
Net Debt 2024 * 1.49B 989M 78.52B Net Debt 2025 * 1.42B 942M 74.84B EV / Sales 2025 * 1.33 x
P/E ratio 2024 *
-1.65 x
P/E ratio 2025 *
33.1 x
Employees 10,500
Yield 2024 *
-
Yield 2025 *
1.6%
Free-Float 87.61%
More Fundamentals * Assessed data
Dynamic Chart
1 day-5.97%
1 week-1.56%
Current month+4.56%
1 month+4.13%
3 months-12.80%
6 months-33.68%
Current year-22.94%
More quotes
1 week
1.22
Extreme 1.22
1.36
1 month
1.08
Extreme 1.08
1.36
Current year
1.08
Extreme 1.08
1.70
1 year
1.08
Extreme 1.08
3.27
3 years
1.08
Extreme 1.08
5.54
5 years
1.08
Extreme 1.08
5.54
10 years
1.08
Extreme 1.08
5.54
More quotes
Managers TitleAgeSince
Chief Executive Officer - 28/02/23
Director of Finance/CFO - 31/01/20
Chief Tech/Sci/R&D Officer - 31/03/21
Members of the board TitleAgeSince
Director/Board Member 67 02/08/15
Chairman 65 24/02/21
Director/Board Member - 30/03/22
More insiders
Date Price Change Volume
15/05/24 1.26 -5.97% 4 603 123
14/05/24 1.34 +4.69% 4,855,644
13/05/24 1.28 +2.40% 1,693,439
10/05/24 1.25 +1.63% 1,538,027
09/05/24 1.23 -3.91% 1,412,904

Delayed Quote Australian S.E., May 15, 2024 at 07:10 am

More quotes
Healius Limited is a healthcare company. The Company’s segments include Pathology, Imaging and Other. The Pathology segment is a provider of pathology services, including specialty pathology and clinical trials. The Imaging segment provides imaging services from standalone imaging sites, hospitals and medical centers. It has a network of pathology laboratories, collection centers and diagnostic imaging centers. It provides specialty diagnostic services to consumers and their referring practitioners. Its brands include Laverty Pathology, QML Pathology, Dorevitch Pathology, Western Diagnostic Pathology, Genomic Diagnostics, Abbott Pathology, IQ Pathology, Vetnostics, TML Vetnostics, Agilex Biolabs, Lumus Imaging, and others. Its Pathology operates 100 medical laboratories and 2,000 patient collection centers across metropolitan, regional and remote Australia. IQ Pathology is a specialized dermatopathology laboratory that provides comprehensive dermatopathology services Australia wide.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
13
Last Close Price
1.34 AUD
Average target price
1.364 AUD
Spread / Average Target
+1.80%
Consensus